Clinical Utility of 18NaF PET/CT in Benign and Malignant Disorders, An Issue of PET Clinics

( 1 )

Overview

The use of F-18 NaF PET/CT versus conventional bone scanning in the assessment of benign and malignant disorders has many advantages, which are discussed at length in this issue. Imaging of a variety of benign and malignant bone diseases is discussed, including the assessment of disease and the monitoring of patient response to therapy. Imaging in pediatric patients is also discussed.

Read More Show Less
... See more details below
Available through our Marketplace sellers.
Other sellers (Hardcover)
  • All (1) from $148.64   
  • New (1) from $148.64   
Close
Sort by
Page 1 of 1
Showing All
Note: Marketplace items are not eligible for any BN.com coupons and promotions
$148.64
Seller since 2011

Feedback rating:

(920)

Condition:

New — never opened or used in original packaging.

Like New — packaging may have been opened. A "Like New" item is suitable to give as a gift.

Very Good — may have minor signs of wear on packaging but item works perfectly and has no damage.

Good — item is in good condition but packaging may have signs of shelf wear/aging or torn packaging. All specific defects should be noted in the Comments section associated with each item.

Acceptable — item is in working order but may show signs of wear such as scratches or torn packaging. All specific defects should be noted in the Comments section associated with each item.

Used — An item that has been opened and may show signs of wear. All specific defects should be noted in the Comments section associated with each item.

Refurbished — A used item that has been renewed or updated and verified to be in proper working condition. Not necessarily completed by the original manufacturer.

New
Brand new and unread! Join our growing list of satisfied customers!

Ships from: Phoenix, MD

Usually ships in 1-2 business days

  • Standard, 48 States
  • Standard (AK, HI)
Page 1 of 1
Showing All
Close
Sort by
Clinical Utility of 18NaF PET/CT in Benign and Malignant Disorders, An Issue of PET Clinics

Available on NOOK devices and apps  
  • NOOK Devices
  • Samsung Galaxy Tab 4 NOOK 7.0
  • Samsung Galaxy Tab 4 NOOK 10.1
  • NOOK HD Tablet
  • NOOK HD+ Tablet
  • NOOK eReaders
  • NOOK Color
  • NOOK Tablet
  • Tablet/Phone
  • NOOK for Windows 8 Tablet
  • NOOK for iOS
  • NOOK for Android
  • NOOK Kids for iPad
  • PC/Mac
  • NOOK for Windows 8
  • NOOK for PC
  • NOOK for Mac
  • NOOK for Web

Want a NOOK? Explore Now

NOOK Book (eBook)
$49.99
BN.com price
(Save 42%)$87.00 List Price

Overview

The use of F-18 NaF PET/CT versus conventional bone scanning in the assessment of benign and malignant disorders has many advantages, which are discussed at length in this issue. Imaging of a variety of benign and malignant bone diseases is discussed, including the assessment of disease and the monitoring of patient response to therapy. Imaging in pediatric patients is also discussed.

Read More Show Less

Product Details

  • ISBN-13: 9781455748860
  • Publisher: Elsevier Health Sciences
  • Publication date: 7/17/2012
  • Series: Clinics: Radiology Series
  • Pages: 240
  • Product dimensions: 7.10 (w) x 10.10 (h) x 0.50 (d)

Table of Contents

Preface Mohsen Beheshti ix

18F NaF PET/CT Versus Conventional Bone Scanning in the Assessment of Benign Bone Disease Klaus Strobel Reza Vali 249

Nuclear physicians in many centers nowadays have the choice of using different nuclear bone-imaging modalities. 18F-labeled sodium fluoride (NaF) PET with computed tomography (PET/CT) is a promising tool for the evaluation of benign bone disease. The indications for NaF PET/CT in clinical practice are probably the same as those established for 99mTc-labeled methylene diphosphonate bone scintigraphy and single-photon emission computed tomography (SPECT)/CT. At present only preliminary data, often with a limited number of patients and lacking comparison with 99mTc-MDP SPECT/CT, are available. This article reviews the available literature and summarizes the authors' experience with NaF PET/CT in benign bone disease.

18F NaF PET/CT in the Assessment of Malignant Bone Disease Camila Mosci Andrei lagaru 263

Diagnostic imaging plays a major role in the evaluation of patients with malignant bone disease. 18F-Labeled sodium fluoride (18F NaF) is a positron-emitting radiopharmaceutical with desirable characteristics (rapid blood clearance and bone uptake) for high-quality functional imaging of the skeleton. In addition to higher sensitivity and specificity, 18F NaF PET combined with computed tomography (PET/CT) allows for shorter imaging time, thus improving patients convenience and benefiting the overall workflow of the imaging facility. Although as yet no robust evidence-based data exist, this article summarizes the published data currently available on the role of 18F NaF PET/CT in the assessment of malignant bone disease.

Quantitative PET Imaging Using 18F Sodium Fluoride in the Assessment of Metabolic Bone Diseases and the Monitoring of Their Response to Therapy Glen M. Blake Musib Siddique Michelle L. Frost Amelia E.B. Moore Ignac Fogelman 275

Studies of bone remodeling using bone biopsy and biochemical markers of bone turnover measured in serum and urine are important for investigating how new treatments for osteoporosis affect bone metabolism. Positron emission tomography with 18F sodium fluoride (18F NaF PET) for studying bone metabolism complements these conventional methods. Unlike biochemical markers, which measure the integrated response to treatment across the whole skeleton, 18F NaF PET can distinguish changes occurring at sites of clinically important osteoporotic fractures. Future studies using 18F NaF PET may illuminate current clinical problems, such as the possible association between long-term treatment with bisphosphonates and atypical fractures of the femur.

Pediatric Bone Scanning: Clinical Indication of 18F NaF PET/CT Laura. A. Drubach 293

Skeletal imaging of children with fluorine-18 (18F) NaF harnesses the superior imaging characteristics of positron emission tomography (PET) and the improved biodistribution of the fluoride tracer compared with standard nuclear techniques, resulting in excellent quality images. Bone malignancy in children is less common than in adults, and the evaluation of benign skeletal disorders represents a larger fraction of indications in the pediatric versus adult population. 18F NaF PET imaging has been successfully applied to various benign disorders, particularly trauma and sports medicine applications.

18F NàF PET/CT in the Assessment of Metastatic Bone Disease: Comparison with Specific PET Tracers Mohsen Beheshti Werner Langsteger 303

The skeletal system is the third most common site of metastases after the lungs and liver, and 80% of all reported metastatic bone disease is in patients with breast and prostate cancer. At present there are an unprecedented number of novel molecular imaging agents potentially available for the assessment of bone metastases in different cancer. This review assesses the role of PET in the imaging of skeletal metastases, focusing on the specific PET tracers (fluorodeoxyglucose, choline derivatives, and so forth), in comparison with 18F NaF as a nonspecific bone-seeking PET agent.

18F NaF PET/CT and Conventional Bone Scanning in Routine Clinical Practice: Comparative Analysis of Tracers, Clinical Acquisition Protocols, and Performance Indices Gad Abikhzer John Kennedy Ora Israel 315

Conventional planar and SPECT bone scintigraphy has long been used and familiarity with this tracer and imaging technique is excellent. 18F NaF PET/CT represents an alternative tracer and imaging modality for the assessment of the skeleton, with the potential to become the gold standard in functional bone imaging. This article com pares the pharmacokinetics, protocols, clinical performance, and cost-effectiveness of the 2 modalities. Technological advances and future directions of both modalities are also discussed.

Value of 18F NaF PET/CT in the Detection and Global Quantification of Cardiovascular Molecular Calcification as Part of the Atherosclerotic Process Sandip Basu Mohsen Beheshti Abass Alavi 329

Detection of early ongoing cardiovascular molecular calcification and its quantification through 18F-labeled sodium fluoride(18F NaF) PET/computed tomography (CT) imaging has been a recent addition to the diagnostic armamentarium of molecular imaging for the atherosclerotic process. At present, visual detection of molecular calcification as well as its regional quantification on (18F NaF) PET/CT are suboptimal, mainly because of the very low degree of uptake of this radiotracer in the heart and major vessels, and hence subject to the partial volume effect. Calculation of car diovascular 18F NaF uptake in the heart and arterial wall using automated software is an innovative approach.

Index 341

Read More Show Less

Customer Reviews

Average Rating 5
( 1 )
Rating Distribution

5 Star

(1)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously
Sort by: Showing 1 Customer Reviews
  • Anonymous

    Posted March 30, 2013

    Wendyll

    Cammie

    Was this review helpful? Yes  No   Report this review
Sort by: Showing 1 Customer Reviews

If you find inappropriate content, please report it to Barnes & Noble
Why is this product inappropriate?
Comments (optional)